Sodium fluxes in human fibroblasts: effect of serum, Ca+2, and amiloride.
Human fibroblasts that have been serum deprived for 4 hours have a digitoxin-insensitive Na influx of 9.5 +/- 1.0 (n = 4) mumol/g prot/min which is not significantly different from the influx of 9.4 +/- 0.6 (n = 3) mumol/g prot/min measured in cells arrested in the G1/G0 state by serum-deprivation for a period of four days. The Na influx in serum-deprived cells is rapidly stimulated (within one minute) simply by assaying the cells in medium containing 10% fetal bovine serum (FBS). The digitoxin-insensitive NA influx for cells in the presence of 10% FBS is 22.9 +/- 1.1 (n = 6) mumol/g prot/min. The stimulation of Na influx in serum-deprived cells can also be achieved by the addition of the purified mitogen, epidermal growth factor (EGF). Addition of EGF to serum-deprived cells gives a maximal stimulation of Na influx of approximately 1.6-fold, with the concentration for half-maximal stimulation being 7.5 ng/ml. The stimulation of Na influx results from the activation of an amiloride-sensitive pathway, which appears to be minimally active in serum-deprived cells. Kinetic analysis of Na influx experiments in the presence of 10% FBS and varying concentrations of amiloride indicate that at infinite concentrations of amiloride the Na flux would be reduced to 8.9 mumol/g prot/min, which is comparable to the level of Na flux measured in serum-deprived cells in the presence of 5 mM amiloride. Thus, amiloride can totally inhibit the serum-stimulated component of Na influx while inhibiting less than 10% of the Na influx in serum-deprived cells. The Na influx in serum-deprived cells can also be stimulated 2.5-fold by preincubating cells in the presence of the Ca+ ionophore A23187 to elevate the intracellular Ca content. This stimulation of Na influx by intracellular Ca+2 can be virtually eliminated by adding 1 mM amiloride.
D000584:Amiloride / Q000494:pharmacology*; D001769:Blood; D002118:Calcium / Q000494:pharmacology*; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005347:Fibroblasts / Q000502:physiology*; D006801:Humans; D008297:Male; D010413:Penis / Q000166:cytology; D011719:Pyrazines / Q000494:pharmacology*; D012964:Sodium / Q000502:physiology*
D011719:Pyrazines; D004815:Epidermal Growth Factor; D000584:Amiloride; D012964:Sodium; D002118:Calcium